These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 25429707)

  • 1. Plasma metabolite biomarkers for the detection of pancreatic cancer.
    Xie G; Lu L; Qiu Y; Ni Q; Zhang W; Gao YT; Risch HA; Yu H; Jia W
    J Proteome Res; 2015 Feb; 14(2):1195-202. PubMed ID: 25429707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of highly sensitive biomarkers that can aid the early detection of pancreatic cancer using GC/MS/MS-based targeted metabolomics.
    Hirata Y; Kobayashi T; Nishiumi S; Yamanaka K; Nakagawa T; Fujigaki S; Iemoto T; Kobayashi M; Okusaka T; Nakamori S; Shimahara M; Ueno T; Tsuchida A; Sata N; Ioka T; Yasunami Y; Kosuge T; Kaneda T; Kato T; Yagihara K; Fujita S; Yamada T; Honda K; Azuma T; Yoshida M
    Clin Chim Acta; 2017 May; 468():98-104. PubMed ID: 28215548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum metabolomics differentiating pancreatic cancer from new-onset diabetes.
    He X; Zhong J; Wang S; Zhou Y; Wang L; Zhang Y; Yuan Y
    Oncotarget; 2017 Apr; 8(17):29116-29124. PubMed ID: 28418859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic classification of pancreatic adenocarcinoma tissue using protein chip technology.
    Scarlett CJ; Smith RC; Saxby A; Nielsen A; Samra JS; Wilson SR; Baxter RC
    Gastroenterology; 2006 May; 130(6):1670-8. PubMed ID: 16697731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LC-MS/MS and SWATH based serum metabolomics enables biomarker discovery in pancreatic cancer.
    Xiong Y; Shi C; Zhong F; Liu X; Yang P
    Clin Chim Acta; 2020 Jul; 506():214-221. PubMed ID: 32243985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commonality and differences of methylation signatures in the plasma of patients with pancreatic cancer and colorectal cancer.
    Melson J; Li Y; Cassinotti E; Melnikov A; Boni L; Ai J; Greenspan M; Mobarhan S; Levenson V; Deng Y
    Int J Cancer; 2014 Jun; 134(11):2656-62. PubMed ID: 24288256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomics identified new biomarkers for the precise diagnosis of pancreatic cancer and associated tissue metastasis.
    Luo X; Liu J; Wang H; Lu H
    Pharmacol Res; 2020 Jun; 156():104805. PubMed ID: 32278036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic signatures and risk of sarcopenia in suburb-dwelling older individuals by LC-MS-based untargeted metabonomics.
    Han P; Chen X; Liang Z; Liu Y; Yu X; Song P; Zhao Y; Zhang H; Zhu S; Shi X; Guo Q
    Front Endocrinol (Lausanne); 2024; 15():1308841. PubMed ID: 38962681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic cancer serum biomarker PC-594: Diagnostic performance and comparison to CA19-9.
    Ritchie SA; Chitou B; Zheng Q; Jayasinghe D; Jin W; Mochizuki A; Goodenowe DB
    World J Gastroenterol; 2015 Jun; 21(21):6604-12. PubMed ID: 26074698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic system alterations in pancreatic cancer patient serum: potential for early detection.
    Ritchie SA; Akita H; Takemasa I; Eguchi H; Pastural E; Nagano H; Monden M; Doki Y; Mori M; Jin W; Sajobi TT; Jayasinghe D; Chitou B; Yamazaki Y; White T; Goodenowe DB
    BMC Cancer; 2013 Sep; 13():416. PubMed ID: 24024929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Multivariate Index for Pancreatic Cancer Detection Based On the Plasma Free Amino Acid Profile.
    Fukutake N; Ueno M; Hiraoka N; Shimada K; Shiraishi K; Saruki N; Ito T; Yamakado M; Ono N; Imaizumi A; Kikuchi S; Yamamoto H; Katayama K
    PLoS One; 2015; 10(7):e0132223. PubMed ID: 26133769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic cancer screening using a multiplatform human serum metabolomics system.
    Sakai A; Suzuki M; Kobayashi T; Nishiumi S; Yamanaka K; Hirata Y; Nakagawa T; Azuma T; Yoshida M
    Biomark Med; 2016 Jun; 10(6):577-86. PubMed ID: 27171159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolomic detection of lung cancer biomarkers in sputum.
    Cameron SJ; Lewis KE; Beckmann M; Allison GG; Ghosal R; Lewis PD; Mur LA
    Lung Cancer; 2016 Apr; 94():88-95. PubMed ID: 26973212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipeline.
    Liu X; Zheng W; Wang W; Shen H; Liu L; Lou W; Wang X; Yang P
    Br J Cancer; 2017 Dec; 117(12):1846-1854. PubMed ID: 29123261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomic profile in pancreatic cancer patients: a consensus-based approach to identify highly discriminating metabolites.
    Di Gangi IM; Mazza T; Fontana A; Copetti M; Fusilli C; Ippolito A; Mattivi F; Latiano A; Andriulli A; Vrhovsek U; Pazienza V
    Oncotarget; 2016 Feb; 7(5):5815-29. PubMed ID: 26735340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Metabolite Profiling for the Detection of Pancreatic Cancer: Results of a Large Independent Validation Study.
    Akita H; Ritchie SA; Takemasa I; Eguchi H; Pastural E; Jin W; Yamazaki Y; Goodenowe DB; Nagano H; Monden M; Mori M; Doki Y
    Pancreas; 2016 Nov; 45(10):1418-1423. PubMed ID: 27518463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of S100P for pancreatic cancer: a meta-analysis.
    Hu H; Zhang Q; Huang C; Shen Y; Chen X; Shi X; Tang W
    Tumour Biol; 2014 Oct; 35(10):9479-85. PubMed ID: 25123266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomic Profiling of Plasma from Patients with Tuberculosis by Use of Untargeted Mass Spectrometry Reveals Novel Biomarkers for Diagnosis.
    Lau SK; Lee KC; Curreem SO; Chow WN; To KK; Hung IF; Ho DT; Sridhar S; Li IW; Ding VS; Koo EW; Wong CF; Tam S; Lam CW; Yuen KY; Woo PC
    J Clin Microbiol; 2015 Dec; 53(12):3750-9. PubMed ID: 26378277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Micro-RNA Alterations Appear Late in Pancreatic Cancer.
    Franklin O; Jonsson P; Billing O; Lundberg E; Öhlund D; Nyström H; Lundin C; Antti H; Sund M
    Ann Surg; 2018 Apr; 267(4):775-781. PubMed ID: 28425921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined serum CA19-9 and miR-27a-3p in peripheral blood mononuclear cells to diagnose pancreatic cancer.
    Wang WS; Liu LX; Li GP; Chen Y; Li CY; Jin DY; Wang XL
    Cancer Prev Res (Phila); 2013 Apr; 6(4):331-8. PubMed ID: 23430754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.